Valuation dashboard for Alcon Inc. (ALC) with P/E 54.96, P/B 1.61, EV/EBITDA 13.90 and dividend yield 0.50%. DCF, Graham Number, EPS growth, peer multiples and dividend discount models plus sector comparison against other Healthcare companies.
Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide. The company operates through two segments, Surgical and Vision Care. It offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures.
Analysis Summary
Alcon Inc. reported revenue of $10.40B in the most recent fiscal year, growing at a 5-year CAGR of 8.8%.
Trailing-twelve-month margins: gross margin 56.5%, operating margin 9.9%, net margin 5.9%.
At $71.45 (closing price, October 30, 2026), ALC trades at a P/E of 54.96 and an ROE of 2.91%. Market capitalisation stands at $34.5B, placing it among large-cap names.
Balance sheet quality for ALC: current ratio of 2.1. A debt-to-equity below 1.0 typically signals conservative capital structure, while a current ratio above 1.5 indicates comfortable short-term liquidity.
Valuation Ratios
| P/E Ratio | 54.96 |
| Price / Book | 1.61 |
| EV / EBITDA | 13.90 |
| Dividend Yield | 0.50% |
Valuation Models
| DCF Fair Value | $69.96 |
| vs Current Price | -2.1% |
Peer Comparison
| Symbol | Company | Market Cap | P/E | P/B | ROE |
|---|---|---|---|---|---|
| ALC | Alcon Inc. | $34.5B | 54.96 | 1.61 | 2.9% |
| COO | The Cooper Companies, Inc. | $11.3B | 20.32 | 1.38 | 6.9% |
| GKOS | Glaukos Corporation | $14.1B | 19.58 | -24.9% | |
| BLCO | Bausch + Lomb Corporation | $7.1B | 1.11 | -1.7% | |
| 0A0D.L | Alcon Inc. | CHF 28.3B | 53.98 | 1.58 | 2.9% |
| STE | STERIS plc | $22.1B | 27.77 | 3.08 | 11.3% |
| 0JZ2.L | Masimo Corporation | $9.5B | 122.42 | 11.91 | 9.0% |
| 0QLQ.L | Ypsomed Holding AG | CHF 4.8B | 23.76 | 7.02 | 28.5% |
Price
| Price | $71.45 (closing price, October 30, 2026) |
| Market Cap | $34.5B |
| Exchange | NYSE |
| Country | CH |
Profitability
| Return on Equity | 2.91% |
| Return on Invested Capital | 3.24% |
| Return on Assets | 2.06% |
| Gross Margin | 56.45% |
| Operating Margin | 9.87% |
| Net Margin | 5.92% |
Related companies: COO · GKOS · BLCO · 0A0D.L · STE · 0JZ2.L · 0QLQ.L · 0A05.L
Explore sector: Healthcare · Medical - Specialties
More sections of ALC: Overview · Financials · Statistics · Estimates · Technical · Ownership · News · Events
Discover more: Weekly Radar: the S&P 500 through the Buffett and Lynch methods · Companies that pass the Buffett method today · Companies that pass the Lynch method today · Stocks that pass Graham's defensive investor test today · Investment Academy — learn to analyze stocks